Home /
zzhang01(AT)pku.edu.cn
ZHANG, Zhe
Title:
Investigator
Office Address: Jinguang Life Science Building,Peking University, No.5 Yiheyuan Road, Haidian District,Beijing, P.R.China 100871
Lab Address: Jinguang Life Science Building,Peking University, No.5 Yiheyuan Road, Haidian District,Beijing, P.R.China 100871
Lab Homepage: http://
Personal Homepage: http://
Resume
Biography
Dr. Zhe Zhang received his B.S. degree in Biotechnology at Shandong University, China in 2008 and Ph.D. degree in Biochemistry and Molecular Biology at the Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, in 2015. Then he moved to New York (USA) and did his postdoctoral research in Jue Chen’s laboratory at the Rockefeller University from 2015 to 2019. He focused on the functional and structural characterization of Rab GTPases during his graduate work, and during his postdoctoral research, he studied ligand-gated ion channels. Dr. Zhang’s work on the cystic fibrosis transmembrane conductance regulator (CFTR) has deepened our mechanistic understanding of this anion channel and has enormous potential for helping people suffering from cystic fibrosis. Dr. Zhang joined the Peking University and PKU-THU Joint Center for Life Sciences (CLS) in July 2019. Now he is working as a Principal Investigator (PI) in the School of Life Sciences to establish the Lab of Membrane Biology and Biophysics.
Education
2008.9-2015.1, Ph.D., Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, Shanghai, China
2004.9-2008.6, B.S., School of Life Sciences, Shandong University, Jinan, China
Professional Experience
2019.7-Now, Principal Investigator, PKU-THU Joint Center for Life Sciences (CLS), Beijing, China
2019.7-Now, Principal Investigator, School of Life Sciences, Peking University, Beijing, China
2015.2-2019.6, Postdoctoral Fellow, The Rockefeller University, New York, NY, USA
Honors and Awards
Best Teaching Award, 2021
Xueersi Boya Young Fellow, 2021
Bayer Investigator, 2020
Yifang Investigator, 2019
Blavatnik Regional Awards for Young Scientists: Life Sciences Finalist, 2018
Tri-Institutional Breakout Prize for Junior Investigators, 2018
Charles H. Revson Senior Fellowship in Biomedical Science, 2017-2019
Research Interests
Membrane proteins constitute about 1/3 of the total proteins in living organisms. Owing to their essential roles in a variety of fundamental biological processes, about 60% of approved drugs target the membrane proteins. Therefore, scientific research on membrane proteins not only has its biological significance, but also plays an important role in the drug development.
Our lab focuses on the mechanistic study of important membrane proteins, especially the disease-related ones, aiming to illustrate their functional mechanisms as well as to guide the downstream drug development. We mainly carry out structural study using single-particle Cryo-EM and X-ray crystallography. In order to thoroughly understand our scientific questions, we also combine biochemical, cell biology, and all the other necessary techniques.
Membrane proteins can be mainly divided into four categories according to their different functions: channels, receptors, transporters, and enzymes. Our lab is particularly interested in two classes of them: transporters and receptors. In the short term, we will first focus on the study of solute carrier (SLC) transporter family. SLC transporters are a kind of secondary transporters, and they are the second largest membrane protein family after GPCR (G-protein coupled receptors). Human has more than 400 SLC transporters which are divided into over 50 subfamilies. SLC transporters passively transport their substrates across the cell membrane down their concentration gradients, or they can transport one substrate against its chemical gradient using the energy from transporting another substrate. The substrates for different SLC members vary greatly, ranging from inorganic ions to neurotransmitters, nutrients, and drugs. In the long term, we will also study different families of membrane receptors, including receptor tyrosine kinases (RTKs) and Notch receptors.
Representative Peer-Reviewed Publications
At PKU:
(*Co-first author, $ Corresponding author)
(1) Zelin Duan*, Xuezhen Lin*, Lixia Wang*, Qiuxin Zhen, Yuefeng Jiang, Chuxin Chen, Jing Yang, Chia-Hsueh Lee, Yan Qin, Ying Li, Bo Zhao$, Jianchuan Wang$, Zhe Zhang$; Specificity of TGF-β1 signal designated by LRRC33 and integrin αVβ8; Nat. Commun.; 2022, 13(1):4988. (doi: 10.1038/s41467-022-32655-9)
(2) Zhaohan Lin, Yinglin Li, Yuqi Hang, Changhe Wang, Bing Liu, Jie Li, Lili Yin, Xiaohan Jiang, Xingyu Du, Zhongjun Qiao, Feipeng Zhu, Zhe Zhang$, Quanfeng Zhang$, Zhuan Zhou$; Tuning the size of large dense-core vesicles and quantal neurotransmitter release via secretogranin II liquid-liquid phase separation; Adv. Sci.; 2022, e2202263. (doi: 10.1002/advs.202202263)
(3) Yansong Zhang, Siyuan Lin, Jingyu Peng, Xiaojuan Liang, Qi Yang, Xue Bai, Yajuan Li, Jinhua Li, Wei Dong, Yue Wang, Ying Huang, Yumeng Pei, Jiabao Guo, Wanni Zhao, Zhe Zhang, Min Liu$, and Alan Jian Zhu$; Amelioration of hepatic steatosis by dietary essential amino acid-induced ubiquitination; Mol. Cell; 2022, 82(8):1528-1542. (doi: 10.1016/j.molcel.2022.01.021)
(4) Yingdi Wang, Yiming Niu, Zhe Zhang, Kenneth Gable, Sita D Gupta, Niranjanakumari Somashekarappa, Gongshe Han, Hongtu Zhao, Alexander G Myasnikov, Ravi C Kalathur, Teresa M Dunn, and Chia-Hsueh Lee$; Structural insights into the regulation of human serine palmitoyltransferase complexes; Nat. Struct. Mol. Biol.; 2021, 28(3): 240-248. (doi: 10.1038/s41594-020-00551-9)
(5) Yuefeng Jiang, Tingting Liu, Chia-Hsueh Lee, Qing Chang, Jing Yang$ and Zhe Zhang$; The NAD+-mediated self-inhibition mechanism of pro-neurodegenerative Sarm1; Nature; 2020, 588(7839): 658-663. (doi: 10.1038/s41586-020-2862-z)

Before PKU:
(1) Fangyu Liu*, Zhe Zhang*, Anat Levit, Jesper Levring, Kouki K. Touhara, Brian K. Shoichet, and Jue Chen$; Structural identification of a hotspot on CFTR for potentiation; Science; 2019,364(6446): 1184-1188. (doi: 10.1126/science.aaw7611)
(2) Zhe Zhang*, Fangyu Liu*, and Jue Chen$; Molecular structure of the ATP-bound, phosphorylated human CFTR; Proc. Natl. Acad. Sci. USA; 2018, 115(50): 12757-12762. (doi: 10.1073/pnas.1815287115)
(3) Zhe Zhang* $, Bal a´zs Tóth*, Andras Szollosi, Jue Chen, and L a´szló Csan a´dy$; Structure of a TRPM2 channel in complex with Ca2+ explains unique gating regulation; eLife; 2018, 7: e36409. (doi: 10.7554/eLife.36409)
(4) Zhe Zhang, Fangyu Liu, and Jue Chen$; Conformational changes of CFTR upon phosphorylation and ATP binding; Cell; 2017, 170(3): 483-491.e8. (doi: 10.1016/j.cell.2017.06.041)
(5) Fangyu Liu*, Zhe Zhang*, L a´szló Csan a´dy, David C Gadsby, and Jue Chen$; Molecular structure of the human CFTR ion channel; Cell; 2017, 169(1): 85-95.e8. (doi: 10.1016/j.cell.2017.02.024)
(6) Zhe Zhang, and Jue Chen$; Atomic structure of the cystic fibrosis transmembrane conductance regulator; Cell; 2016, 167(6): 1586-1597.e9. (doi: 10.1016/j.cell.2016.11.014)
(7) Zhe Zhang*, ShanshanWang*, Tong Shen, Jiangye Chen, and Jianping Ding$; Crystal structure of the Rab9A-RUTBC2 RBD complex reveals the molecular basis for the binding specificity of Rab9A with RUTBC2; Structure; 2014, 22 (10): 1408-1422. (doi: 10.1016/j.str.2014.08.005)
(8) Zhe Zhang, Tianlong Zhang, Shanshan Wang, Zhou Gong, Chun Tang, Jiangye Chen, and Jianping Ding$; Molecular mechanism for Rabex-5 GEF activation by Rabaptin-5; eLife; 2014, 3: e02687. (doi: 10.7554/eLife.02687)
Teaching
Biochemistry
Laboratory Introduction